Assertio holdings, inc. reports inducement grants under nasdaq listing rule 5635(c)(4)

Lake forest, ill., july 09, 2024 (globe newswire) -- assertio holdings, inc. (“assertio” or the “company”) (nasdaq: asrt), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that effective july 1, 2024, the compensation committee of the company's board of directors granted four newly-hired employees a total of 44,575 restricted stock units (“rsus”) and 142,910 stock options (“options”).
ASRT Ratings Summary
ASRT Quant Ranking